5 of 390 shown
Lobbying reported per quarter
reported amounts per quarter, latest version of each report
There are two charts here because there are two different amounts. A lobbying firm reports income: what it was paid. A company that lobbies for itself reports expenses: what it spent, under one of three accounting methods it picks itself. Both appear under this company, and they are not the same measurement — so they are never added, not in a bar and not in a total.
Reported income: what lobbying firms reported receiving from this company's clients, per quarter.
Reported expenses: what this company reported spending on its own lobbying, per quarter, under the accounting method it picked itself.
Before 2025, these bars cover only the lobbying relationships that were still active in 2025 or later. Engagements that ended earlier are not included, so those years may be higher than shown.
Reported income
Reported expenses
Recent activity
Register facts only. Everything on this page comes from filings made under the Lobbying Disclosure Act of 1995 and kept by the Secretary of the Senate. We read the filings, we link a client to a listed company where a reviewed rule allows it, and we add nothing else. No score, no ranking and no judgement is attached to lobbying on this site. See the methodology and about this site.
28 superseded versions left out of the quarterly sums, listed here.
| Registrant | Filing | Amount | Posted | Registrant | Amount | Filing | All amounts | Posted |
|---|---|---|---|---|---|---|---|---|
| PHRONESISDC, LLCfor ABBOTT LABORATORIES | 3rd Quarter - Report3rd Quarter 2026 | $50,000incomeposted Oct 20, 2026 (LD-2 at lda.gov) | Oct 20, 2026 (LD-2 at lda.gov) | PHRONESISDC, LLCfor ABBOTT LABORATORIES | $50,000 | 3rd Quarter - Report3rd Quarter 2026 | $50,000income | Oct 20, 2026 (LD-2 at lda.gov) |
| DUDDINGTON GLOBAL STRATEGIES LLCfor ABBOTT LABORATORIES | 3rd Quarter - Report3rd Quarter 2026 | $10,000incomeposted Oct 20, 2026 (LD-2 at lda.gov) | Oct 20, 2026 (LD-2 at lda.gov) | DUDDINGTON GLOBAL STRATEGIES LLCfor ABBOTT LABORATORIES | $10,000 | 3rd Quarter - Report3rd Quarter 2026 | $10,000income | Oct 20, 2026 (LD-2 at lda.gov) |
| MARSHALL & POPP, LLCfor ABBOTT LABORATORIES | 3rd Quarter - Report3rd Quarter 2026 | $60,000incomeposted Oct 20, 2026 (LD-2 at lda.gov) | Oct 20, 2026 (LD-2 at lda.gov) | MARSHALL & POPP, LLCfor ABBOTT LABORATORIES | $60,000 | 3rd Quarter - Report3rd Quarter 2026 | $60,000income | Oct 20, 2026 (LD-2 at lda.gov) |
| THE DUBERSTEIN GROUP INC.for ABBOTT LABORATORIES | 3rd Quarter - Report (No Activity)3rd Quarter 2026 | no activityas reportedposted Oct 20, 2026 (LD-2 at lda.gov) | Oct 20, 2026 (LD-2 at lda.gov) | THE DUBERSTEIN GROUP INC.for ABBOTT LABORATORIES | no activity | 3rd Quarter - Report (No Activity)3rd Quarter 2026 | no activityas reported | Oct 20, 2026 (LD-2 at lda.gov) |
| ABBOTT LABORATORIESfor ABBOTT LABORATORIES | 3rd Quarter - Report3rd Quarter 2026 | $1,300,000expenses (A)posted Oct 20, 2026 (LD-2 at lda.gov) | Oct 20, 2026 (LD-2 at lda.gov) | ABBOTT LABORATORIESfor ABBOTT LABORATORIES | $1,300,000 | 3rd Quarter - Report3rd Quarter 2026 | $1,300,000expenses (A) | Oct 20, 2026 (LD-2 at lda.gov) |
The link between the client names above and ABT is a reviewed rule of ours, not something the filing states: an LD-2 names a client and carries no ticker, no CIK and no LEI.